MedPath

PIK3CA

Generic Name
PIK3CA
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
-
Unique Ingredient Identifier
JQ83GG8LT2
Background

PIK3CA is under investigation in clinical trial NCT02957266 (Cervical Cancer Radiotherapy by Use of VMAT, Individualized Polyradiosensitization and Interstitial Brachytherapy).

Associated Conditions
-
Associated Therapies
-
© Copyright 2025. All Rights Reserved by MedPath